Disease-free survival 36 months [clinicaltrials_resource:de97a21f17027e73aac29401f1999fcf]
weekly paclitaxel 50mg/m2 plus weekly cisplatin 25mg/m2 5times with concurrent radiotherapy (5000rad/25fx) for 5 weeks followed by 2 cycles of 3-weekly paclitaxel (175mg/m2) plus cisplatin 80mg/m2.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Disease-free survival 36 months [clinicaltrials_resource:de97a21f17027e73aac29401f1999fcf]
weekly paclitaxel 50mg/m2 plus weekly cisplatin 25mg/m2 5times with concurrent radiotherapy (5000rad/25fx) for 5 weeks followed by 2 cycles of 3-weekly paclitaxel (175mg/m2) plus cisplatin 80mg/m2.
Bio2RDF identifier
de97a21f17027e73aac29401f1999fcf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:de97a21f17027e73aac29401f1999fcf
measure [clinicaltrials_vocabulary:measure]
Disease-free survival
time frame [clinicaltrials_vocabulary:time-frame]
description
weekly paclitaxel 50mg/m2 plus ...... mg/m2) plus cisplatin 80mg/m2.
identifier
clinicaltrials_resource:de97a21f17027e73aac29401f1999fcf
title
Disease-free survival 36 months
@en
type
label
Disease-free survival 36 month ...... 7a21f17027e73aac29401f1999fcf]
@en